Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs) ; volume:23 ; number:2 ; day:14 ; month:3 ; year:2021 ; pages:1-12 ; date:3.2021
The AAPS journal / American Association of Pharmaceutical Scientists ; 23, Heft 2 (14.3.2021), 1-12, 3.2021
- Creator
-
Bozza, William P.
Takeda, Kazuyo
Alterovitz, Wei-Lun
Chou, Chao-Kai
Shen, Rong-Fong
Zhang, Baolin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1208/s12248-021-00576-y
- URN
-
urn:nbn:de:101:1-2021052820254820334071
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bozza, William P.
- Takeda, Kazuyo
- Alterovitz, Wei-Lun
- Chou, Chao-Kai
- Shen, Rong-Fong
- Zhang, Baolin
- SpringerLink (Online service)
Other Objects (12)
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Anthracycline Chemotherapy and Cardiotoxicity
Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Detection of anthracycline-induced cardiotoxicity using perfusion-corrected 99mTc sestamibi SPECT
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Anthracycline Chemotherapy and Cardiotoxicity
Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Detection of anthracycline-induced cardiotoxicity using perfusion-corrected 99mTc sestamibi SPECT
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Anthracycline Chemotherapy and Cardiotoxicity
Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes